Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 7/20 | 0.42 |
| ▸ | BACE2 | Q9Y5Z0 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18636673 | 0.87 | BACE1 (0.47) | BACE1BACE2 | |
| SCHEMBL4083524 | 0.81 | BACE1 (0.38) | BACE1BACE2ALDH1A1GAATHRB | |
| SCHEMBL4078985 | 0.81 | BACE1 (0.39) | BACE1BACE2ALDH1A1GAATHRB | |
| SCHEMBL18623909 | 0.80 | BACE1 (0.45) | BACE1BACE2ALDH1A1HTTL3MBTL1 | |
| SCHEMBL18636959 | 0.80 | BACE1 (0.41) | BACE1BACE2ALDH1A1GAATHRB | |
| SCHEMBL18636674 | 0.79 | BACE1 (0.61) | BACE1BACE2 | |
| SCHEMBL17169022 | 0.79 | BACE1 (0.57) | BACE1BACE2ALDH1A1HTTLMNA | |
| SCHEMBL2109485 | 0.74 | BACE2 (0.40) | BACE1BACE2ALDH1A1GAATHRB | |
| SCHEMBL6890355 | 0.73 | BACE2 (0.40) | BACE1BACE2ALDH1A1GAATHRB | |
| SCHEMBL15934114 | 0.71 | BACE1 (0.47) | BACE1BACE2AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170073337-A1 | DIHYDROTHIAZINE AND DIHYDROOXAZINE DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170073337-A1 | DIHYDROTHIAZINE AND DIHYDROOXAZINE DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY | BACE1, BACE2, APP | BACE1 1/4885BACE2 2/4885ALDH1A1 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.